AceView offers a comprehensive annotation of human, mouse and nematode genes
reconstructed by co-alignment and clustering of all publicly available
mRNAs and ESTs on the genome sequence. Our goals are to offer a reliable
up-to-date resource on the genes, their functions, alternative variants,
expression, regulation and interactions, in the hope to stimulate
further validating experiments at the bench
This site normally requires a frame enabled viewer,
However, click here to access our full description of gene MRPS6andSLC5A3andC21orf82.
, go to our main page or see our latest news
Homo sapiens complex locus MRPS6andSLC5A3andC21orf82, encoding solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 and mitochondrial ribosomal protein S6.
TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Compact gene diagram
Alternative mRNAs are shown aligned from 5' to 3' on a virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, intron height reflects the number of cDNAs supporting each intron. Introns of the same color are identical, of different colors are different. 'Good proteins' are pink, partial or not-good proteins are yellow, uORFs are green. 5' cap or3' poly A flags show completeness of the transcript.
Read more...
Mouse over the ending of each transcript gives tissues from which the supporting cDNAs were extracted. Details on tissue of origin for each intron and exon is available from the
intron and exons table.
Click on any transcript to open the specific mRNA page, to see the exact cDNA clone support and eventual SNPs and to get details on tissues, sequences, mRNA and protein annotations. Proteins supported by a single continuous cDNA sequence lead to underlining the name/ending of the variant. Names not underlined result from cDNA concatenation in the coding region and should be experimentally checked.
Introns are depicted by broken lines; the height of the top of each intron reflects the relative number of clones supporting this intron.
]^[ A pink broken line denotes an intron with standard boundaries (gt-ag or gc-ag) that is exactly supported (i.e. a cDNA sequence exactly matches the genome over 16 bp, 8 on both sides of the intron).
] ^ ] A blue broken line denotes non-standard introns, exactly supported, but with non-standard at-ac or any other boundaries.
]-[ Pink and
] - ] blue straight lines represent 'fuzzy' introns of the standard and non-standard types respectively, those introns do not follow the 16 bp rule. Black straight lines ]-[denote gaps in the alignments.
Exons: Wide filled pink areas represent putative protein coding regions, narrow empty pink boxes represent the 5'UTR (on the left) and 3' UTR (on the right). Flags identify validated endings: cap site on the 5' side, polyadenylation site on the 3' side. Filled flags correspond to frequent events while empty flags have lesser supporting cDNAs (yet all are validated); at the 3' side, black flags are associated to the main AATAAA signal,
blue flags to any single letter variant of the main . More explanations are given in the
gene help file
Expression and GenBank cDNA support
Tissues where expression was observed (from 544 cDNA clones)
Origin of the cDNAs, as reported in GenBank/dbEST (tissue, stage, pathological or normal) shows that the gene is expressed in brain (seen 66 times), hypothalamus (34), lung (31), uterus (26), kidney (23), head neck (20), eye (18), glioblastoma (pooled) (18), breast carcinoma (17), placenta (15), testis (12), colon (11), head normal (11), total brain (10), heart (9), hippocampus (9), stomach (8), liver (7), pooled human melanocyte, fetal heart, andpregnant uterus (7), skin (7), whole embryo, mainly head (7), chondrosarcoma (6), ovary (6), blood vessels - aorta, basilar and artery (5), breast (5), carcinoid (5), human lung epithelial cells (5), lens (5), pancreas (5), pooled germ cell tumors (5), prostate (5), thymus (5), adenocarcinoma (4), epidermoid carcinoma, cell line (4), leiomyosarcoma cell line (4), lymph (4), lymphoma, cell line (4), rpe/choroid (4), skeletal muscle (4), thyroid gland (4), trachea (4), 2 pooled tumors (clear cell type) (3), adipose (3), adrenal gland (3), amygdala (3), bladder (3), bone (3), cerebellum (3), cochlea (3), ear (3), embryonic stem cell, retinoic acid andmitogen-treated hes cell line H7 (3), embryonic stem cells, dmso-treated H9 cellline (3), endometrium, adenocarcinoma cell line (3), left pelvis (3), left pubic bone (3), medulla (3), melanotic melanoma (3), normal prostate (3), salivary gland (3), testis normal (3), thalamus (3), transitional cell papilloma, cell line (3), adenocarcinoma cell line (2), alveolar macrophage (2), anaplastic oligodendroglioma (2), ascites (2), b-cells (2), brain, cerebellum, PCR rescued clones (2), cell lines (2), chondrosarcoma grade II (2), chondrosarcoma lung metastasis cell lines (2), choriocarcinoma (2), ductal carcinoma, cell line (2), duodenal adenocarcinoma, cell line (2), embryonic stem cells, cell lines H1, H7, andh9 (2), enchondroma cell line (2), fetal eyes, lens, eye anterior segment,optic nerve, retina, retina foveal and macular, RPE andchoroid (2), germinal center B cell (2), malignant melanoma, metastatic to lymphnode (2), nervous normal (2), nervous tumor (2), neuroblastoma (2), neuroblastoma, cell line (2), optic nerve (2), ovary, tumor tissue (2), pooled-skin (2), poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors (2), primary b-cells from tonsils (cell line) (2), primary lung cystic fibrosis epithelialcells (2), RPE and choroid (2), small intestine (2), spleen (2), whole brain (2), wilms' tumor, cell line (2), 2 pooled high-grade transitional celltumors (once), 2 pooled wilms' tumors, one primary and onemetastatic to brain (once), adenocarcinoma, cell line (once), beard hair (once), blood (once), brain, neuroblastoma (once), cervix (once), connective tissue (once), cornea (once), denis drash (once), embryonal carcinoma, cell line (once), embryonic stem cells (once), embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells (once), epithelioid carcinoma (once), fetal brain (once), five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma (once), four pooled poorly-differentiatedadenocarcinomas (once), genitourinary tract (once), germ cell tumor (once), glioblastoma with probably TP53 mutation andwithout EGFR amplification (once), hela cells cot 25-normalized (once), hip (once), human amygdala (once), human embryonic stem cells differentiated toan early endodermal cell type (once), human skeletal muscle (once), juvenile granulosa tumor (once), kidney tumor (once), kidney, renal cell adenocarcinoma (once), large cell carcinoma (once), leiomyosarcoma (once), leukopheresis (once), leukoplakia of the buccal mucosa (once), liver and spleen (once), lung tumor (once), melanocyte (once), melanotic melanoma, cell line (once), metastatic prostate bone lesion (once), moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors (once), mouth (once), natural killer cells, cell line (once), neuroblastoma cot 10-normalized (once), pineal gland (once), pituitary (once), pool of melanoma cell lines (once), pooled colon, kidney, stomach (once), pooled pancreas and spleen (once), pooled-glandular (once), posterior rhombomeres 5-8 (4 pooled) (once), primary b-cells from tonsils (once), primary lung epithelial cells (once), primitive neuroectoderm (once), purified pancreatic islet (once), retinoblastoma (once), schwannoma tumor (once), serous papillary carcinoma, high grade, 2pooled tumors (once), squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) (once), subthalamic nucleus (once), sympathetic trunk (once), t-lymphocytes (once), teratocarcinoma, cell line (once), trabecular meshwork (once), uterus, leiomyosarcoma (once), uterus tumor (once), well-differentiated endometrialadenocarcinoma, 7 pooled tumors (once).
544 cDNA clones support the 20 variants of gene MRPS6andSLC5A3andC21orf82
?
This table helps analyze the pattern of expression of the gene, the tissue, cell type or disease state specificity of the alternative variants and to select cDNA clones suitable for your experiments.
cDNA accession Links to the sequence |
Tissue
most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features |
Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AX750578 | | .a | 1 to 10294 | 1 to 10297 | exact | tiling clone, | | 10297/10302 (99 %) | 37 diff (99.7 %id) |
NM_006933.4 | | .a | 1 to 11579 | 1 to 11579 | exact | RefSeq, | | 11579/11579 (100 %) | 3 diff (100.0 %id) |
DA723865 | | .a | 8 to 534 | 2 to 527 | | tiling clone, capped | | 526/526 (100 %) | 3 diff (99.5 %id) |
DA511408 | brain | .a | 9 to 570 | 2 to 561 | | capped | | 560/560 (100 %) | 4 diff (99.3 %id) |
DA510954 | brain | .a | 10 to 590 | 2 to 580 | | capped | | 579/579 (100 %) | 3 diff (99.5 %id) |
DA570729 | whole embryo, mainly head | .a | 10 to 824 | 2 to 814 | | capped | | 813/813 (100 %) | 8 diff (99.1 %id) |
AX750579 | | .a | 513 to 2669 | 1 to 2157 | exact | | | 2157/2157 (100 %) | 0 diff (100 %id) |
CV391258 | nervous_normal | .a | 646 to 1162 | 14 to 533 | | | | 520/533 (97 %) | 6 diff (98.9 %id) |
BF375312 | stomach | .a | 1077 to 1377 | 20 to 320 | | | | 301/369 (81 %) | 15 diff (96.0 %id) |
BE089541 | breast | .a | 1175 to 1522 | 1 to 348 | | | | 348/348 (100 %) | 10 diff (97.2 %id) |
BP290336 | lung | .a | 1227 to 1752 | 1 to 526 | | | | 526/534 (98 %) | 4 diff (99.3 %id) |
BM839239 | Ascites, stomach | .a | 1288 to 1803 | 1 to 515 | | | | 515/515 (100 %) | 4 diff (99.3 %id) |
DA570585 | whole embryo, mainly head | .a | 1506 to 2161 | 2 to 657 | | capped | | 656/699 (93 %) | 3 diff (99.6 %id) |
AA157355 | Pancreas | .a | 2021 to 2084 | 1 to 64 | | | | 64/64 (100 %) | 0 diff (100 %id) |
BF507722 | | .a | 2064 to 2238 | 11 to 185 | | | Submitted on the opposite strand | 175/185 (94 %) | 6 diff (96.8 %id) |
AL833562 | human amygdala | .a | 2443 to 8629 | 1 to 6189 | | tiling clone, available from DKFZ, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 6189/6189 (100 %) | 13 diff (99.8 %id) |
CN303345 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 2692 to 3423 | 1 to 735 | | | | 735/735 (100 %) | 9 diff (98.8 %id) |
CA392094 | eye, RPE/choroid | .a | 3233 to 3702 | 1 to 471 | | | | 471/471 (100 %) | 1 diff (99.8 %id) |
X83558 | fetal brain | .a | 3866 to 4950 | 1 to 1087 | | | | 1087/1091 (99 %) | 24 diff (97.9 %id) |
M78393 | | .a | 3870 to 4248 | 1 to 382 | | | | 382/382 (100 %) | 3 diff (99.3 %id) |
BM562952 | duodenal adenocarcinoma, cell line, small intestine | .a | 3994 to 4941 | 1 to 951 | | | | 951/1058 (89 %) | 27 diff (97.5 %id) |
FN126445 | breast carcinoma | .a | 4358 to 4446 | 1 to 88 | | | | 88/88 (100 %) | 4 diff (95.5 %id) |
DA496842 | brain | .a | 4464 to 5035 | 2 to 574 | | capped | | 573/573 (100 %) | 4 diff (99.4 %id) |
DA736946 | | .a | 4584 to 5398 | 2 to 819 | | tiling clone, capped | | 818/818 (100 %) | 13 diff (98.5 %id) |
DA320522 | hippocampus | .a | 4773 to 5218 | 2 to 448 | | capped | | 447/447 (100 %) | 3 diff (99.4 %id) |
AL700649 | human skeletal muscle | .a | 4966 to 5445 | 1 to 480 | | | | 480/480 (100 %) | 2 diff (99.6 %id) |
DB238031 | trachea | .a | 5216 to 5806 | 2 to 593 | | capped | | 592/592 (100 %) | 1 diff (99.9 %id) |
BX498679 | Liver | .a | 5321 to 5865 | 1 to 545 | | | | 545/545 (100 %) | 3 diff (99.5 %id) |
DA783014 | brain | .a | 5711 to 6283 | 2 to 574 | | capped | | 573/573 (100 %) | 0 diff (100 %id) |
DA158634 | amygdala | .a | 5714 to 6222 | 2 to 510 | | capped | | 509/509 (100 %) | 0 diff (100 %id) |
DA859190 | placenta | .a | 5755 to 6296 | 2 to 543 | | capped | | 542/542 (100 %) | 1 diff (99.9 %id) |
AA489889 | | .a | 5776 to 6195 | 1 to 420 | | | | 420/420 (100 %) | 1 diff (99.8 %id) |
AK092248 | | .a | 6010 to 8628 | 1 to 2619 | | available from FLJ, | | 2619/2620 (99 %) | 5 diff (99.9 %id) |
DA741739 | | .a | 6011 to 6530 | 2 to 523 | | capped | | 522/522 (100 %) | 2 diff (99.7 %id) |
BG569470 | Liver | .a | 6310 to 7087 | 1 to 772 | | | | 772/801 (96 %) | 13 diff (98.4 %id) |
DA484176 | brain | .a | 6399 to 6869 | 2 to 472 | | capped | | 471/471 (100 %) | 0 diff (100 %id) |
CD250640 | Blood vessels - aorta, basilar and artery | .a | 6414 to 7131 | 1 to 725 | | | | 725/731 (99 %) | 13 diff (98.3 %id) |
Z45933 | brain, total brain | .a | 6439 to 6728 | 1 to 289 | | | | 289/289 (100 %) | 1 diff (99.7 %id) |
BM472758 | duodenal adenocarcinoma, cell line, small intestine | .a | 6481 to 7378 | 1 to 917 | | | | 917/1002 (91 %) | 24 diff (97.7 %id) |
D53651 | | .a | 6499 to 6977 | 1 to 478 | | | | 478/478 (100 %) | 1 diff (99.8 %id) |
DN912120 | | .a | 6526 to 7186 | 1 to 661 | | | | 661/662 (99 %) | 3 diff (99.6 %id) |
DA568042 | whole embryo, mainly head | .a | 6661 to 7370 | 2 to 719 | | capped | | 718/722 (99 %) | 13 diff (98.2 %id) |
CN303347 | embryonic stem cells, DMSO-treated H9 cellline | .a | 6663 to 7189 | 1 to 527 | | | | 527/527 (100 %) | 0 diff (100 %id) |
DA812113 | ovary, tumor tissue | .a | 6674 to 7352 | 2 to 679 | | capped | | 678/678 (100 %) | 2 diff (99.8 %id) |
DB165905 | thyroid gland | .a | 6692 to 7431 | 2 to 738 | | capped | | 737/738 (99 %) | 8 diff (99.0 %id) |
DA819081 | | .a | 6786 to 7339 | 2 to 556 | | capped | | 555/555 (100 %) | 1 diff (99.9 %id) |
DA063300 | cerebellum | .a | 6831 to 7389 | 2 to 561 | | capped | | 560/560 (100 %) | 1 diff (99.9 %id) |
DA330244 | hippocampus | .a | 6833 to 7291 | 2 to 461 | | capped | | 460/460 (100 %) | 1 diff (99.8 %id) |
BG287582 | bladder, transitional cell papilloma, cell line | .a | 6890 to 7536 | 1 to 646 | | | | 646/927 (69 %) | 9 diff (99.1 %id) |
DA568625 | whole embryo, mainly head | .a | 6938 to 7799 | 2 to 856 | | capped | | 855/875 (97 %) | 19 diff (97.9 %id) |
DA358215 | subthalamic nucleus | .a | 6952 to 7521 | 2 to 573 | | capped | | 572/572 (100 %) | 4 diff (99.4 %id) |
BE177668 | head_neck | .a | 7101 to 7728 | 2 to 625 | | | | 624/625 (99 %) | 6 diff (99.1 %id) |
DA327694 | hippocampus | .a | 7189 to 7662 | 2 to 474 | | capped | | 473/473 (100 %) | 2 diff (99.6 %id) |
DA307192 | hippocampus | .a | 7284 to 7745 | 2 to 464 | | capped | | 463/463 (100 %) | 2 diff (99.6 %id) |
BQ232870 | large cell carcinoma, lung | .a | 7367 to 8371 | 1 to 1008 | | tiling clone, | | 1008/1048 (96 %) | 19 diff (98.2 %id) |
F05432 | brain, total brain | .a | 7388 to 7622 | 1 to 234 | | | | 234/234 (100 %) | 4 diff (98.3 %id) |
Z44108 | brain, total brain | .a | 7388 to 7718 | 1 to 331 | | | | 331/331 (100 %) | 3 diff (99.1 %id) |
F11694 | brain, total brain | .a | 7388 to 7686 | 1 to 300 | | | | 300/300 (100 %) | 10 diff (96.7 %id) |
AW955106 | | .a | 7421 to 8050 | 1 to 627 | | | | 627/627 (100 %) | 13 diff (98.0 %id) |
BG993944 | head_neck | .a | 7479 to 7638 | 159 to 3 | | | | 157/189 (83 %) | 0 diff (100 %id) |
CA392093 | eye, RPE/choroid | .a | 7519 to 8029 | 527 to 17 | | AAA | | 511/511 (100 %) | 8 diff (98.5 %id) |
FN148557 | breast carcinoma | .a | 7608 to 7715 | 107 to 1 | | | Submitted on the opposite strand | 107/107 (100 %) | 1 diff (99.1 %id) |
DB064440 | testis | .a | 7638 to 8205 | 2 to 569 | | capped | | 568/568 (100 %) | 0 diff (100 %id) |
BI494523 | cochlea, ear | .a | 7676 to 8038 | 1 to 363 | | fully sequenced, | | 363/363 (100 %) | 5 diff (98.7 %id) |
BF381997 | brain, primitive neuroectoderm | .a | 7681 to 8430 | 1 to 741 | | | | 741/802 (92 %) | 33 diff (95.9 %id) |
W72666 | heart | .a | 7752 to 8277 | 1 to 538 | | | Submitted on the opposite strand | 538/584 (92 %) | 18 diff (97.0 %id) |
BG254534 | adenocarcinoma, cell line, Prostate | .a | 7776 to 8515 | 1 to 745 | | | | 745/1252 (59 %) | 19 diff (98.5 %id) |
AI871766 | carcinoid, lung | .a | 7785 to 8277 | 1 to 493 | | | Submitted on the opposite strand | 493/493 (100 %) | 0 diff (100 %id) |
DA756696 | | .a | 7807 to 8322 | 2 to 517 | | capped | | 516/516 (100 %) | 3 diff (99.5 %id) |
AW770731 | carcinoid, lung | .a | 7809 to 8255 | 1 to 447 | | | Submitted on the opposite strand | 447/447 (100 %) | 0 diff (100 %id) |
DB288068 | uterus | .a | 7820 to 8379 | 2 to 561 | | capped | | 560/560 (100 %) | 1 diff (99.9 %id) |
FN088614 | breast carcinoma | .a | 7828 to 7927 | 99 to 1 | | | Submitted on the opposite strand | 99/99 (100 %) | 2 diff (98.0 %id) |
DA213959 | brain | .a | 7865 to 8397 | 2 to 534 | | capped | | 533/533 (100 %) | 0 diff (100 %id) |
DB217312 | trachea | .a | 7891 to 8455 | 2 to 566 | | capped | | 565/565 (100 %) | 3 diff (99.5 %id) |
DA211956 | brain | .a | 7996 to 8547 | 2 to 553 | | capped | | 552/552 (100 %) | 0 diff (100 %id) |
BI494522 | cochlea, ear | .a | 8008 to 8646 | 639 to 1 | | fully sequenced, | | 639/639 (100 %) | 3 diff (99.6 %id) |
DN912121 | | .a | 8045 to 8620 | 576 to 1 | | | | 576/576 (100 %) | 2 diff (99.7 %id) |
BF195231 | carcinoid, lung | .a | 8049 to 8320 | 17 to 288 | | | Submitted on the opposite strand | 272/288 (94 %) | 6 diff (98.0 %id) |
DN919191 | | .a | 8069 to 8549 | 498 to 18 | | | | 481/498 (96 %) | 0 diff (100 %id) |
BX118830 | placenta | .a | 8073 to 8629 | 1 to 556 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 556/556 (100 %) | 1 diff (99.9 %id) |
DB142970 | thymus | .a | 8075 to 8536 | 2 to 463 | | capped | | 462/462 (100 %) | 1 diff (99.8 %id) |
DB354504 | whole embryo, mainly head | .a | 8076 to 8629 | 556 to 1 | | | | 556/556 (100 %) | 10 diff (98.3 %id) |
DB350427 | trachea | .a | 8076 to 8629 | 555 to 1 | | | | 555/555 (100 %) | 1 diff (99.9 %id) |
DB355157 | whole embryo, mainly head | .a | 8081 to 8629 | 549 to 1 | | | | 549/552 (99 %) | 6 diff (99.0 %id) |
DB381758 | thyroid gland | .a | 8081 to 8629 | 547 to 1 | | | | 547/552 (99 %) | 11 diff (98.1 %id) |
DB315672 | brain | .a | 8082 to 8629 | 552 to 1 | | | | 552/552 (100 %) | 4 diff (99.3 %id) |
DB369516 | | .a | 8085 to 8629 | 548 to 1 | | | | 548/549 (99 %) | 19 diff (96.6 %id) |
DB371415 | ovary, tumor tissue | .a | 8085 to 8629 | 548 to 1 | | | | 548/592 (92 %) | 10 diff (98.4 %id) |
DB297136 | cerebellum | .a | 8096 to 8629 | 536 to 1 | | | | 536/536 (100 %) | 2 diff (99.7 %id) |
BG056536 | brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification | .a | 8096 to 8630 | 535 to 1 | | | | 535/535 (100 %) | 1 diff (99.9 %id) |
DA802624 | brain | .a | 8135 to 8679 | 2 to 546 | | tiling clone, capped | | 545/545 (100 %) | 0 diff (100 %id) |
DA802687 | brain | .a | 8135 to 8688 | 2 to 557 | | capped | | 556/556 (100 %) | 2 diff (99.7 %id) |
AI867198 | Kidney | .a | 8149 to 8629 | 481 to 1 | | | | 484/484 (100 %) | 0 diff (100 %id) |
DA218790 | brain | .a | 8159 to 8707 | 2 to 552 | | capped | | 551/551 (100 %) | 2 diff (99.7 %id) |
DB357367 | whole embryo, mainly head | .a | 8160 to 8629 | 471 to 1 | | | | 471/471 (100 %) | 10 diff (97.9 %id) |
FN112805 | breast carcinoma | .a | 8197 to 8262 | 66 to 1 | | | Submitted on the opposite strand | 66/66 (100 %) | 0 diff (100 %id) |
BF509918 | | .a | 8207 to 8629 | 440 to 18 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 423/424 (99 %) | 1 diff (99.8 %id) |
W76424 | heart | .a | 8208 to 8629 | 431 to 1 | | | Submitted on the opposite strand | 431/436 (98 %) | 10 diff (97.8 %id) |
AW104950 | pooled | .a | 8210 to 8633 | 424 to 1 | | | | 424/424 (100 %) | 0 diff (100 %id) |
AI244880 | Kidney | .a | 8212 to 8629 | 418 to 1 | | | | 418/418 (100 %) | 2 diff (99.6 %id) |
DB139884 | thymus | .a | 8215 to 8724 | 2 to 513 | | capped | | 512/512 (100 %) | 1 diff (99.9 %id) |
AW241378 | connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma | .a | 8227 to 8630 | 404 to 1 | | | | 404/404 (100 %) | 0 diff (100 %id) |
AI640590 | Kidney | .a | 8238 to 8764 | 530 to 2 | | | | 529/530 (99 %) | 0 diff (100 %id) |
DA407558 | thalamus | .a | 8241 to 8796 | 2 to 557 | | capped | | 556/556 (100 %) | 0 diff (100 %id) |
DA503769 | brain | .a | 8244 to 8779 | 2 to 539 | | capped | | 538/538 (100 %) | 1 diff (99.9 %id) |
AA490044 | | .a | 8251 to 8628 | 378 to 1 | | | | 378/378 (100 %) | 0 diff (100 %id) |
AI991426 | Kidney | .a | 8270 to 8629 | 360 to 1 | | | | 360/360 (100 %) | 0 diff (100 %id) |
AI399928 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 8287 to 8767 | 482 to 1 | | | | 482/482 (100 %) | 1 diff (99.8 %id) |
Z40123 | brain, total brain | .a | 8313 to 8629 | 317 to 1 | | | | 317/317 (100 %) | 0 diff (100 %id) |
F09353 | brain, total brain | .a | 8315 to 8629 | 315 to 1 | | | | 315/315 (100 %) | 0 diff (100 %id) |
CA390529 | eye, RPE/choroid | .a | 8322 to 8871 | 1 to 550 | | | | 550/550 (100 %) | 0 diff (100 %id) |
F01696 | brain, total brain | .a | 8338 to 8629 | 292 to 1 | | | | 292/292 (100 %) | 0 diff (100 %id) |
DA122569 | cerebellum | .a | 8339 to 8860 | 2 to 524 | | capped | | 523/523 (100 %) | 3 diff (99.5 %id) |
FN067469 | breast carcinoma | .a | 8343 to 8396 | 54 to 1 | | | Submitted on the opposite strand | 54/55 (98 %) | 0 diff (100 %id) |
DA518317 | brain | .a | 8350 to 8900 | 2 to 551 | | capped | | 550/550 (100 %) | 1 diff (99.9 %id) |
DA144213 | amygdala | .a | 8376 to 8943 | 2 to 572 | | capped | | 571/571 (100 %) | 3 diff (99.5 %id) |
FN126592 | breast carcinoma | .a | 8379 to 8475 | 100 to 1 | | | Submitted on the opposite strand | 100/101 (99 %) | 3 diff (97.1 %id) |
CN303346 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 8407 to 9062 | 1 to 657 | | | | 657/657 (100 %) | 1 diff (99.9 %id) |
F04791 | brain, total brain | .a | 8418 to 8629 | 213 to 2 | | | | 212/213 (99 %) | 0 diff (100 %id) |
D60544 | | .a | 8419 to 8629 | 211 to 1 | | | | 211/212 (99 %) | 3 diff (98.6 %id) |
AA523328 | metastatic prostate bone lesion | .a | 8446 to 8635 | 190 to 1 | | | | 190/197 (96 %) | 3 diff (98.5 %id) |
FN151730 | breast carcinoma | .a | 8462 to 8541 | 81 to 2 | | | Submitted on the opposite strand | 80/81 (98 %) | 0 diff (100 %id) |
DA779905 | brain | .a | 8526 to 9101 | 2 to 579 | | capped | | 578/578 (100 %) | 1 diff (99.9 %id) |
DA513521 | brain | .a | 8540 to 9098 | 2 to 561 | | capped | | 560/560 (100 %) | 1 diff (99.9 %id) |
DA781695 | brain | .a | 8541 to 9107 | 2 to 571 | | capped | | 570/570 (100 %) | 3 diff (99.5 %id) |
DR158454 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 8599 to 9392 | 1 to 794 | | tiling clone, | | 794/794 (100 %) | 0 diff (100 %id) |
W16611 | lung | .a | 8686 to 9154 | 1 to 465 | | | | 465/489 (95 %) | 10 diff (98.0 %id) |
DA654217 | | .a | 8717 to 9307 | 2 to 594 | | capped | | 593/593 (100 %) | 2 diff (99.7 %id) |
DA781802 | brain | .a | 8754 to 9344 | 2 to 592 | | capped | | 591/591 (100 %) | 0 diff (100 %id) |
DA010309 | adrenal gland | .a | 8816 to 9363 | 2 to 549 | | capped | | 548/548 (100 %) | 2 diff (99.7 %id) |
BX505522 | | .a | 8908 to 9578 | 1 to 672 | | | | 672/672 (100 %) | 2 diff (99.8 %id) |
BM457528 | embryonal carcinoma, cell line, testis | .a | 8990 to 9662 | 11 to 683 | | | | 673/1182 (56 %) | 23 diff (98.1 %id) |
AA621183 | | .a | 9045 to 9492 | 461 to 14 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 448/448 (100 %) | 0 diff (100 %id) |
CD653745 | Embryonic Stem cells | .a | 9092 to 9929 | 3 to 837 | | | | 835/839 (99 %) | 6 diff (99.3 %id) |
DA629555 | Kidney | .a | 9147 to 9682 | 2 to 537 | | capped | | 536/536 (100 %) | 0 diff (100 %id) |
BQ228934 | melanotic melanoma, skin | .a | 9212 to 9972 | 1 to 771 | | AAA | | 771/869 (88 %) | 23 diff (97.4 %id) |
CN314471 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 9216 to 9855 | 1 to 641 | | | | 641/641 (100 %) | 3 diff (99.6 %id) |
AA449060 | | .a | 9317 to 9886 | 1 to 570 | | | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 570/570 (100 %) | 0 diff (100 %id) |
AW373631 | breast | .a | 9340 to 9936 | 599 to 3 | | | | 597/631 (94 %) | 0 diff (100 %id) |
AW373773 | breast | .a | 9340 to 9924 | 585 to 3 | | | | 583/595 (97 %) | 0 diff (100 %id) |
DB166016 | thyroid gland | .a | 9391 to 10159 | 2 to 770 | | tiling clone, capped | | 769/849 (90 %) | 6 diff (99.3 %id) |
DA155301 | amygdala | .a | 9415 to 9986 | 2 to 574 | | capped | | 573/573 (100 %) | 1 diff (99.9 %id) |
AA570382 | Schwannoma tumor | .a | 9447 to 9766 | 1 to 320 | | | Submitted on the opposite strand | 320/320 (100 %) | 0 diff (100 %id) |
AB074183 | | .a | 9499 to 11576 | 1 to 2078 | | tiling clone, | | 2078/2081 (99 %) | 2 diff (100.0 %id) |
AU253668 | neuroblastoma | .a | 9499 to 10150 | 49 to 700 | | | | 652/687 (94 %) | 6 diff (99.2 %id) |
BQ722584 | sympathetic trunk | .a | 9538 to 10431 | 1 to 901 | | | | 901/981 (91 %) | 31 diff (96.9 %id) |
BE696753 | colon | .a | 9562 to 9744 | 185 to 6 | | | | 180/185 (97 %) | 0 diff (100 %id) |
BE696754 | colon | .a | 9562 to 9754 | 198 to 5 | | | | 194/198 (97 %) | 0 diff (100 %id) |
BF375832 | testis_normal | .a | 9562 to 9741 | 184 to 6 | | | | 179/184 (97 %) | 0 diff (100 %id) |
CB959259 | Pooled-Glandular | .a | 9600 to 10249 | 1 to 657 | | AAA | | 657/794 (82 %) | 9 diff (98.9 %id) |
Z41910 | brain, total brain | .a | 9615 to 9898 | 1 to 284 | | | | 284/284 (100 %) | 2 diff (99.3 %id) |
BG286986 | bladder, transitional cell papilloma, cell line | .a | 9672 to 10363 | 1 to 695 | | | | 695/978 (71 %) | 12 diff (98.8 %id) |
BE708320 | head_neck | .a | 9711 to 9878 | 1 to 168 | | | | 168/168 (100 %) | 0 diff (100 %id) |
AK024896 | colon | .a | 9712 to 11573 | 1 to 1862 | | tiling clone, available from FLJ, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 1862/1862 (100 %) | 2 diff (99.9 %id) |
DB023687 | testis | .a | 9740 to 10282 | 2 to 544 | | capped | | 543/543 (100 %) | 0 diff (100 %id) |
CD109106 | brain, Pituitary | .a | 9891 to 10665 | 26 to 803 | | | | 778/871 (89 %) | 16 diff (98.2 %id) |
BF826559 | head_normal | .a | 9932 to 10286 | 356 to 3 | | | Submitted on the opposite strand | 354/358 (98 %) | 0 diff (100 %id) |
BF826571 | head_normal | .a | 9932 to 10248 | 331 to 14 | | | Submitted on the opposite strand | 318/333 (95 %) | 0 diff (100 %id) |
BF826626 | head_normal | .a | 9932 to 10278 | 353 to 8 | | | Submitted on the opposite strand | 346/355 (97 %) | 0 diff (100 %id) |
BF826630 | head_normal | .a | 9932 to 10238 | 308 to 2 | | | Submitted on the opposite strand | 307/310 (99 %) | 0 diff (100 %id) |
BF826733 | head_normal | .a | 9932 to 10055 | 134 to 14 | | | Submitted on the opposite strand | 121/136 (88 %) | 0 diff (100 %id) |
BF826737 | head_normal | .a | 9932 to 10181 | 250 to 4 | | | Submitted on the opposite strand | 247/253 (97 %) | 0 diff (100 %id) |
BF827757 | head_normal | .a | 9932 to 10181 | 254 to 6 | | | Submitted on the opposite strand | 249/256 (97 %) | 0 diff (100 %id) |
BF827760 | head_normal | .a | 9932 to 10236 | 305 to 1 | | | Submitted on the opposite strand | 305/307 (99 %) | 0 diff (100 %id) |
BF834652 | head_neck | .a | 9932 to 10180 | 255 to 6 | | | Submitted on the opposite strand | 250/257 (97 %) | 0 diff (100 %id) |
BF834658 | head_neck | .a | 9932 to 10246 | 321 to 4 | | | Submitted on the opposite strand | 318/323 (98 %) | 0 diff (100 %id) |
BF834664 | head_neck | .a | 9932 to 10278 | 351 to 7 | | | Submitted on the opposite strand | 345/353 (97 %) | 0 diff (100 %id) |
BF836814 | head_neck | .a | 9932 to 10164 | 284 to 49 | | | Submitted on the opposite strand | 236/286 (82 %) | 0 diff (100 %id) |
BF836819 | head_neck | .a | 9932 to 10196 | 271 to 7 | | | Submitted on the opposite strand | 265/273 (97 %) | 0 diff (100 %id) |
BF836828 | head_neck | .a | 9932 to 10248 | 322 to 6 | | | Submitted on the opposite strand | 317/324 (97 %) | 0 diff (100 %id) |
BF879147 | lung_tumor | .a | 9932 to 10148 | 220 to 3 | | | Submitted on the opposite strand | 218/222 (98 %) | 0 diff (100 %id) |
BQ354397 | head_neck | .a | 9932 to 10245 | 365 to 48 | | | | 318/367 (86 %) | 0 diff (100 %id) |
BQ354398 | head_neck | .a | 9932 to 10278 | 354 to 4 | | | | 351/356 (98 %) | 0 diff (100 %id) |
BF834663 | head_neck | .a | 9935 to 10156 | 250 to 29 | | | Submitted on the opposite strand | 222/250 (88 %) | 8 diff (96.8 %id) |
BF834660 | head_neck | .a | 9957 to 10273 | 1 to 318 | | | | 318/318 (100 %) | 2 diff (99.4 %id) |
CD357148 | Blood vessels - aorta, basilar and artery | .a | 10069 to 10796 | 1 to 738 | | | | 738/747 (98 %) | 16 diff (97.9 %id) |
AK026169 | | .a | 10077 to 11573 | 1 to 1496 | | available from FLJ, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 1496/1496 (100 %) | 5 diff (99.7 %id) |
BM705661 | eye, lens | .a | 10127 to 10492 | 1 to 366 | | | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 366/366 (100 %) | 0 diff (100 %id) |
FN096158 | breast carcinoma | .a | 10163 to 10252 | 88 to 1 | | | Submitted on the opposite strand | 88/89 (98 %) | 3 diff (96.7 %id) |
ES316282 | pool of melanoma cell lines | .a | 10177 to 10698 | 67 to 587 | | | | 521/587 (88 %) | 4 diff (99.4 %id) |
CD299220 | Blood vessels - aorta, basilar and artery | .a | 10206 to 10926 | 1 to 729 | | | | 729/821 (88 %) | 20 diff (97.6 %id) |
DN912062 | | .a | 10223 to 10893 | 1 to 671 | | | | 671/671 (100 %) | 3 diff (99.6 %id) |
BU156601 | eye, retinoblastoma | .a | 10282 to 11157 | 1 to 886 | | | | 886/889 (99 %) | 17 diff (98.1 %id) |
BG426564 | Kidney | .a | 10432 to 11188 | 1 to 758 | | | | 758/878 (86 %) | 33 diff (96.3 %id) |
BM083590 | Kidney | .a | 10433 to 10995 | 1 to 563 | | | | 563/563 (100 %) | 3 diff (99.5 %id) |
AA029258.
matches multiple genes | uterus | .a | 10437 to 10609 | 1 to 173 | | | also hits gene ORMDL3 | 173/173 (100 %) | 0 diff (100 %id) |
BQ014703 | Chondrosarcoma, Left Pubic Bone | .a | 10568 to 11345 | 794 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 776/776 (100 %) | 3 diff (99.7 %id) |
CD356074 | Blood vessels - aorta, basilar and artery | .a | 10576 to 11244 | 1 to 676 | | | | 676/759 (89 %) | 18 diff (97.7 %id) |
FN061057 | breast carcinoma | .a | 10584 to 10650 | 67 to 1 | | | Submitted on the opposite strand | 67/68 (98 %) | 1 diff (98.6 %id) |
CA313245 | Human Lung Epithelial cells, lung | .a | 10601 to 11327 | 732 to 5 | | | | 728/742 (98 %) | 0 diff (100 %id) |
AW770987 | carcinoid, lung | .a | 10631 to 11020 | 1 to 390 | | | Submitted on the opposite strand | 390/390 (100 %) | 2 diff (99.5 %id) |
CD104043 | Pooled-Skin | .a | 10660 to 11391 | 1 to 737 | | | | 737/785 (93 %) | 14 diff (98.3 %id) |
BF033754 | adenocarcinoma, ovary | .a | 10670 to 11319 | 1 to 650 | | | | 650/811 (80 %) | 10 diff (98.8 %id) |
FN087493 | breast carcinoma | .a | 10788 to 10893 | 1 to 109 | | | | 109/109 (100 %) | 3 diff (97.3 %id) |
TI_157612844 | | .a | 10817 to 11573 | 862 to 108 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 755/755 (100 %) | 13 diff (98.3 %id) |
CD675371 | eye, lens | .a | 10861 to 11471 | 611 to 1 | | | Submitted on the opposite strand | 611/611 (100 %) | 0 diff (100 %id) |
DA831126 | placenta | .a | 10875 to 11575 | 2 to 702 | | fully sequenced, capped | | 701/701 (100 %) | 15 diff (97.9 %id) |
BM997002 | Chondrosarcoma, Left Pubic Bone | .a | 10890 to 11573 | 701 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 683/683 (100 %) | 4 diff (99.5 %id) |
BQ003126 | Chondrosarcoma, Left Pelvis | .a | 10910 to 11573 | 682 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 664/664 (100 %) | 1 diff (99.9 %id) |
BG401754 | Kidney | .a | 10941 to 11573 | 1 to 626 | | | | 626/777 (80 %) | 16 diff (98.0 %id) |
CV414315 | testis_normal | .a | 10946 to 11224 | 1 to 284 | | | | 284/284 (100 %) | 24 diff (91.6 %id) |
FN048913 | breast carcinoma | .a | 10964 to 11025 | 62 to 1 | | | Submitted on the opposite strand | 62/62 (100 %) | 0 diff (100 %id) |
CB250671 | Human Lung Epithelial cells, lung | .a | 10996 to 11573 | 597 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 579/579 (100 %) | 1 diff (99.9 %id) |
DB320792 | Kidney | .a | 11006 to 11573 | 569 to 1 | | | | 569/569 (100 %) | 1 diff (99.9 %id) |
BU734941 | eye, lens | .a | 11015 to 11573 | 577 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 559/565 (98 %) | 0 diff (100 %id) |
DN912061 | | .a | 11023 to 11559 | 537 to 1 | | | | 537/537 (100 %) | 0 diff (100 %id) |
DB381922 | thyroid gland | .a | 11023 to 11573 | 549 to 1 | | | | 549/549 (100 %) | 7 diff (98.8 %id) |
AI935495 | Kidney | .a | 11035 to 11573 | 539 to 1 | | | | 539/539 (100 %) | 0 diff (100 %id) |
AI819745 | 2 pooled tumors (clear cell type), Kidney | .a | 11041 to 11574 | 538 to 3 | | | | 536/538 (99 %) | 0 diff (100 %id) |
BE858479 | brain, glioblastoma (pooled) | .a | 11046 to 11572 | 529 to 3 | | | | 527/529 (99 %) | 0 diff (100 %id) |
BE349513 | malignant melanoma, metastatic to lymphnode, skin | .a | 11054 to 11573 | 520 to 1 | | | | 520/520 (100 %) | 1 diff (99.9 %id) |
BF431203 | Kidney | .a | 11055 to 11566 | 511 to 1 | | | | 511/511 (100 %) | 1 diff (99.9 %id) |
TI_149279655 | | .a | 11057 to 11573 | 59 to 575 | | AAA | Submitted on the opposite strand | 517/575 (89 %) | 4 diff (99.4 %id) |
BF939562 | brain, glioblastoma (pooled) | .a | 11058 to 11565 | 508 to 1 | | | | 508/508 (100 %) | 0 diff (100 %id) |
BM969678 | lung, Primary Lung Epithelial Cells | .a | 11059 to 11573 | 1 to 515 | | AAA | Submitted on the opposite strand | 515/515 (100 %) | 2 diff (99.7 %id) |
CA314093 | Human Lung Epithelial cells, lung | .a | 11059 to 11573 | 1 to 515 | | AAA | Submitted on the opposite strand | 515/515 (100 %) | 2 diff (99.7 %id) |
CA311809 | Human Lung Epithelial cells, lung | .a | 11059 to 11573 | 1 to 515 | | AAA | Submitted on the opposite strand | 515/515 (100 %) | 2 diff (99.7 %id) |
AI422744 | brain, glioblastoma (pooled) | .a | 11065 to 11573 | 509 to 1 | | | | 509/509 (100 %) | 0 diff (100 %id) |
AI423415 | brain, glioblastoma (pooled) | .a | 11065 to 11565 | 501 to 1 | | | | 501/501 (100 %) | 0 diff (100 %id) |
AW771111 | colon, juvenile granulosa tumor | .a | 11068 to 11556 | 489 to 1 | | | | 489/489 (100 %) | 1 diff (99.8 %id) |
BG054840 | brain, glioblastoma (pooled) | .a | 11069 to 11573 | 505 to 1 | | | | 505/505 (100 %) | 0 diff (100 %id) |
AI140447 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 11080 to 11573 | 494 to 1 | | | | 494/494 (100 %) | 2 diff (99.6 %id) |
BG285457 | bladder, transitional cell papilloma, cell line | .a | 11080 to 11573 | 1 to 490 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 490/490 (100 %) | 6 diff (98.8 %id) |
BF509654 | | .a | 11082 to 11573 | 509 to 18 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 492/492 (100 %) | 1 diff (99.8 %id) |
AI332649 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 11088 to 11573 | 486 to 1 | | | | 486/486 (100 %) | 0 diff (100 %id) |
AI969550 | malignant melanoma, metastatic to lymphnode, skin | .a | 11088 to 11574 | 490 to 4 | | | | 487/490 (99 %) | 0 diff (100 %id) |
BX105035 | whole brain | .a | 11089 to 11572 | 498 to 15 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 484/484 (100 %) | 2 diff (99.6 %id) |
FN161487 | breast carcinoma | .a | 11106 to 11215 | 1 to 106 | | | | 106/108 (98 %) | 5 diff (95.4 %id) |
AI942442 | anaplastic oligodendroglioma, brain | .a | 11112 to 11573 | 476 to 15 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 462/462 (100 %) | 0 diff (100 %id) |
AI199841 | placenta | .a | 11118 to 11574 | 458 to 2 | | | | 457/458 (99 %) | 0 diff (100 %id) |
AI129261 | uterus | .a | 11119 to 11573 | 455 to 1 | | | | 455/455 (100 %) | 0 diff (100 %id) |
AI422431 | brain, glioblastoma (pooled) | .a | 11119 to 11574 | 457 to 2 | | | | 456/457 (99 %) | 0 diff (100 %id) |
AI140453 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 11122 to 11573 | 452 to 1 | | | | 452/452 (100 %) | 0 diff (100 %id) |
AI419482 | brain, glioblastoma (pooled) | .a | 11122 to 11565 | 444 to 1 | | | | 444/444 (100 %) | 0 diff (100 %id) |
AI050878 | brain, glioblastoma (pooled) | .a | 11125 to 11574 | 450 to 1 | | | | 450/450 (100 %) | 0 diff (100 %id) |
AI080121 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 11138 to 11573 | 436 to 1 | | | | 436/436 (100 %) | 0 diff (100 %id) |
AI280479 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 11145 to 11573 | 429 to 1 | | | | 429/429 (100 %) | 0 diff (100 %id) |
AI423608 | brain, glioblastoma (pooled) | .a | 11162 to 11565 | 403 to 1 | | | | 403/403 (100 %) | 1 diff (99.8 %id) |
AI372882 | uterus | .a | 11172 to 11573 | 415 to 14 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 402/402 (100 %) | 0 diff (100 %id) |
CA393235 | eye, RPE/choroid | .a | 11175 to 11573 | 1 to 399 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 399/399 (100 %) | 1 diff (99.8 %id) |
AA678475 | | .a | 11187 to 11573 | 387 to 1 | | | | 387/387 (100 %) | 0 diff (100 %id) |
AI221599 | placenta | .a | 11203 to 11574 | 373 to 2 | | | | 372/373 (99 %) | 0 diff (100 %id) |
BE551776 | pooled germ cell tumors | .a | 11207 to 11570 | 368 to 4 | | | | 365/368 (99 %) | 0 diff (100 %id) |
AA807943 | normal prostate, Prostate | .a | 11208 to 11573 | 399 to 34 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 366/366 (100 %) | 0 diff (100 %id) |
N79574 | lung | .a | 11212 to 11576 | 365 to 1 | | | | 365/365 (100 %) | 0 diff (100 %id) |
AI375330 | brain, glioblastoma (pooled) | .a | 11219 to 11565 | 347 to 1 | | | | 347/347 (100 %) | 0 diff (100 %id) |
AA449772 | | .a | 11233 to 11573 | 351 to 11 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 341/341 (100 %) | 0 diff (100 %id) |
AI094106 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 11243 to 11573 | 344 to 14 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 331/331 (100 %) | 0 diff (100 %id) |
AW627793 | 2 pooled high-grade transitional celltumors, genitourinary tract | .a | 11249 to 11573 | 354 to 29 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 326/326 (100 %) | 2 diff (99.4 %id) |
DB376630 | placenta | .a | 11267 to 11575 | 305 to 1 | | fully sequenced, | | 305/305 (100 %) | 0 diff (100 %id) |
AI014757 | germ cell tumor | .a | 11323 to 11573 | 251 to 1 | | | | 251/251 (100 %) | 0 diff (100 %id) |
BE245261 | leukopheresis | .a | 11365 to 11574 | 212 to 3 | | | | 210/212 (99 %) | 0 diff (100 %id) |
T24879 | | .a | 11382 to 11563 | 179 to 1 | | | | 179/179 (100 %) | 9 diff (95.0 %id) |
Z38205 | brain, total brain | .a | 11391 to 11573 | 184 to 1 | | | | 184/184 (100 %) | 1 diff (99.5 %id) |
AI540756 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 11401 to 11573 | 173 to 1 | | | | 173/174 (99 %) | 0 diff (100 %id) |
TI_154110336 | | .b | 1 to 951 | 973 to 35 | G2M A5L L6S M7W G8* | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 939/985 (95 %) | 19 diff (98.1 %id) |
BG759899 | B-cells, primary B-cells from tonsils (cell line) | .c | 1 to 605 | 33 to 637 | exact | tiling clone, | | 605/638 (94 %) | 7 diff (99.0 %id) |
TI_57166238 | | .d | 1 to 823 | 27 to 847 | exact | tiling clone, | | 821/847 (96 %) | 14 diff (98.4 %id) |
AY061855 | | .d | 5 to 994 | 1 to 990 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 990/990 (100 %) | 1 diff (99.9 %id) |
BI835068 | pooled pancreas and spleen | .d | 5 to 823 | 1 to 817 | exact | | | 817/817 (100 %) | 10 diff (98.8 %id) |
NM_032476.3 | | .d | 5 to 994 | 1 to 990 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 990/990 (100 %) | 0 diff (100 %id) |
DB484286 | hypothalamus | .d | 9 to 454 | 1 to 446 | | | | 446/446 (100 %) | 0 diff (100 %id) |
DB487590 | hypothalamus | .d | 9 to 450 | 1 to 442 | | | | 442/442 (100 %) | 1 diff (99.8 %id) |
DB495285 | hypothalamus | .d | 9 to 497 | 1 to 489 | | | | 489/489 (100 %) | 3 diff (99.4 %id) |
CB128613 | Liver | .d | 29 to 566 | 1 to 538 | exact | | | 538/538 (100 %) | 0 diff (100 %id) |
BM563952 | blood, natural killer cells, cell line | .d | 45 to 961 | 1 to 927 | exact | | | 927/1160 (79 %) | 30 diff (97.5 %id) |
TI_45209084 | | .d | 54 to 944 | 87 to 977 | exact | | | 891/1022 (87 %) | 20 diff (98.1 %id) |
TI_44343522 | | .d | 54 to 880 | 121 to 947 | P97H E104N C105V E106K I108L ... | | | 827/947 (87 %) | 17 diff (98.3 %id) |
BG714495 | brain, hypothalamus | .d | 55 to 856 | 1 to 801 | P97H E104N C105V E106K I108L ... | | | 801/802 (99 %) | 10 diff (98.8 %id) |
BG714571 | brain, hypothalamus | .d | 55 to 804 | 1 to 757 | exact | | | 757/757 (100 %) | 19 diff (97.5 %id) |
BG706954 | brain, hypothalamus | .d | 55 to 740 | 1 to 685 | exact | | | 685/686 (99 %) | 4 diff (99.5 %id) |
BG714757 | brain, hypothalamus | .d | 55 to 884 | 1 to 829 | I93X | | | 829/830 (99 %) | 16 diff (98.1 %id) |
BG709078 | brain, hypothalamus | .d | 55 to 875 | 1 to 820 | R90T G91R N92E I93Y V94C ... | | | 820/824 (99 %) | 12 diff (98.6 %id) |
BG715315 | brain, hypothalamus | .d | 55 to 757 | 1 to 704 | exact | | | 704/707 (99 %) | 7 diff (99.1 %id) |
BG703468 | brain, hippocampus | .d | 55 to 917 | 1 to 856 | P16T K116T L117I Y118I S119F ... | | | 856/882 (97 %) | 21 diff (97.7 %id) |
BG720377 | testis | .d | 55 to 733 | 1 to 679 | exact | | | 679/679 (100 %) | 2 diff (99.8 %id) |
BI596656 | brain, hypothalamus | .d | 55 to 944 | 1 to 890 | exact | | | 890/911 (97 %) | 19 diff (98.0 %id) |
BI667563 | brain, hypothalamus | .d | 55 to 880 | 1 to 826 | P97H E104N C105V E106K I108L ... | | | 826/826 (100 %) | 12 diff (98.6 %id) |
BP197721 | adrenal gland | .d | 58 to 639 | 1 to 582 | exact | | | 582/582 (100 %) | 0 diff (100 %id) |
BG684737 | B-cells, primary B-cells from tonsils (cell line) | .d | 58 to 944 | 1 to 892 | exact | | | 892/917 (97 %) | 21 diff (97.8 %id) |
AB049942 | | .d | 59 to 686 | 1 to 628 | exact | | | 628/628 (100 %) | 1 diff (99.9 %id) |
BE439855 | Trabecular meshwork | .d | 59 to 820 | 1 to 747 | exact | | | 747/747 (100 %) | 18 diff (97.6 %id) |
BP225803 | | .d | 59 to 639 | 1 to 581 | exact | | | 581/581 (100 %) | 2 diff (99.7 %id) |
AK312084 | | .d | 60 to 560 | 1 to 501 | exact | | | 501/501 (100 %) | 0 diff (100 %id) |
BM834091 | stomach | .d | 60 to 617 | 1 to 558 | exact | | | 558/558 (100 %) | 0 diff (100 %id) |
BM830659 | stomach | .d | 60 to 617 | 1 to 558 | exact | | | 558/558 (100 %) | 0 diff (100 %id) |
BM831419 | stomach | .d | 60 to 617 | 1 to 558 | K116X | | | 558/558 (100 %) | 0 diff (100 %id) |
DA554872 | | .d | 61 to 628 | 2 to 569 | exact | capped | | 568/568 (100 %) | 0 diff (100 %id) |
BM821506 | stomach | .d | 61 to 651 | 1 to 592 | exact | | | 592/592 (100 %) | 3 diff (99.5 %id) |
DA898464 | skeletal muscle | .d | 61 to 612 | 2 to 553 | exact | capped | | 552/552 (100 %) | 0 diff (100 %id) |
DB459929 | testis | .d | 62 to 513 | 1 to 452 | | | | 452/452 (100 %) | 0 diff (100 %id) |
DB462109 | testis | .d | 62 to 534 | 1 to 473 | | | | 473/474 (99 %) | 1 diff (99.8 %id) |
DB473873 | hippocampus | .d | 62 to 542 | 1 to 483 | | | | 483/483 (100 %) | 2 diff (99.6 %id) |
DB489660 | hypothalamus | .d | 62 to 522 | 1 to 461 | | | | 461/461 (100 %) | 0 diff (100 %id) |
DB492765 | hypothalamus | .d | 62 to 519 | 1 to 458 | | | | 458/459 (99 %) | 3 diff (99.4 %id) |
DB495279 | hypothalamus | .d | 62 to 553 | 1 to 492 | | | | 492/492 (100 %) | 4 diff (99.2 %id) |
DB500157 | hypothalamus | .d | 62 to 563 | 1 to 504 | L22* | | | 504/504 (100 %) | 10 diff (98.1 %id) |
DB502810 | hypothalamus | .d | 62 to 263 | 1 to 204 | | | | 204/204 (100 %) | 5 diff (97.6 %id) |
DB505131 | hypothalamus | .d | 62 to 519 | 1 to 458 | | | | 458/458 (100 %) | 0 diff (100 %id) |
DB505132 | hypothalamus | .d | 62 to 521 | 1 to 460 | | | | 460/460 (100 %) | 0 diff (100 %id) |
DB495421 | hypothalamus | .d | 64 to 570 | 1 to 507 | P112A | | | 507/507 (100 %) | 1 diff (99.9 %id) |
BM464948 | lymph, lymphoma, cell line | .d | 65 to 719 | 6 to 662 | exact | | | 657/1188 (55 %) | 24 diff (98.0 %id) |
CN368391 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .d | 66 to 763 | 1 to 699 | exact | | | 699/699 (100 %) | 5 diff (99.3 %id) |
BQ672514 | epidermoid carcinoma, cell line, salivary gland | .d | 68 to 992 | 1 to 935 | exact | | | 935/936 (99 %) | 19 diff (98.0 %id) |
BF684993 | leiomyosarcoma cell line, uterus | .d | 70 to 855 | 1 to 794 | P16Q E17R T18L A19L A20L ... | | | 794/878 (90 %) | 29 diff (96.7 %id) |
BF686572 | leiomyosarcoma cell line, uterus | .d | 70 to 955 | 1 to 881 | I93X I108M | | | 881/1075 (81 %) | 60 diff (94.5 %id) |
BQ071658 | brain, neuroblastoma, cell line | .d | 70 to 986 | 1 to 918 | exact | | | 918/923 (99 %) | 6 diff (99.4 %id) |
TI_57147732 | | .d | 70 to 856 | 60 to 846 | exact | | | 787/847 (92 %) | 10 diff (98.9 %id) |
BC004976 | Kidney, renal cell adenocarcinoma | .d | 71 to 988 | 1 to 918 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 918/918 (100 %) | 1 diff (99.9 %id) |
BC010076 | Uterus, leiomyosarcoma | .d | 71 to 988 | 1 to 918 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 918/919 (99 %) | 2 diff (99.8 %id) |
CR590691 | HeLa cells Cot 25-normalized | .d | 71 to 944 | 1 to 874 | exact | | | 874/874 (100 %) | 0 diff (100 %id) |
AL555227 | placenta | .d | 71 to 944 | 1 to 874 | exact | fully sequenced, | | 874/874 (100 %) | 3 diff (99.7 %id) |
DN991004 | brain, whole brain | .d | 71 to 770 | 1 to 700 | exact | | | 700/700 (100 %) | 4 diff (99.5 %id) |
CV569210 | cornea, eye | .d | 72 to 665 | 1 to 594 | exact | | | 594/594 (100 %) | 0 diff (100 %id) |
BC000547 | Brain, neuroblastoma | .d | 73 to 994 | 1 to 922 | exact | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 922/922 (100 %) | 0 diff (100 %id) |
BM040734 | Kidney, Wilms' tumor, cell line | .d | 73 to 928 | 1 to 855 | P16Q E17R T18L A19L A20L ... | fully sequenced, | | 855/855 (100 %) | 47 diff (94.6 %id) |
BQ708576 | Spleen | .d | 73 to 984 | 1 to 922 | exact | | | 922/951 (96 %) | 22 diff (97.7 %id) |
BG025229 | lymph, lymphoma, cell line | .d | 74 to 805 | 1 to 734 | G33E A34S I35N V36S R37E ... | | | 734/968 (75 %) | 15 diff (98.5 %id) |
BG339365 | leiomyosarcoma cell line, uterus | .d | 74 to 864 | 1 to 774 | exact | | | 774/892 (86 %) | 28 diff (96.9 %id) |
TI_154194100 | | .d | 74 to 971 | 46 to 929 | exact | | | 884/1006 (87 %) | 20 diff (98.1 %id) |
BU174789 | ductal carcinoma, cell line, Pancreas | .d | 76 to 798 | 1 to 727 | G33* | | | 727/901 (80 %) | 13 diff (98.6 %id) |
BQ690956 | ductal carcinoma, cell line, Pancreas | .d | 76 to 773 | 1 to 703 | G33* | | | 703/783 (89 %) | 7 diff (99.2 %id) |
CF128254 | Chondrosarcoma Lung Metastasis cell lines, lung | .d | 76 to 853 | 1 to 776 | exact | | | 776/776 (100 %) | 4 diff (99.5 %id) |
BI760749 | pooled colon, kidney, stomach | .d | 77 to 856 | 1 to 779 | exact | | | 779/780 (99 %) | 5 diff (99.4 %id) |
BQ672980 | epidermoid carcinoma, cell line, salivary gland | .d | 78 to 988 | 1 to 916 | exact | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 916/916 (100 %) | 13 diff (98.6 %id) |
BM705169 | eye, RPE and Choroid | .d | 78 to 438 | 1 to 361 | | | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 361/361 (100 %) | 1 diff (99.8 %id) |
CB267538 | adipose | .d | 80 to 666 | 1 to 587 | exact | | | 587/587 (100 %) | 1 diff (99.9 %id) |
CB268539 | adipose | .d | 82 to 638 | 1 to 557 | exact | | | 557/557 (100 %) | 1 diff (99.9 %id) |
TI_57218275 | | .d | 84 to 560 | 33 to 515 | I86T D87R V88L I89* | | | 483/519 (93 %) | 19 diff (96.4 %id) |
BQ947008 | epidermoid carcinoma, cell line, lung | .d | 91 to 981 | 1 to 901 | exact | | | 901/948 (95 %) | 17 diff (98.3 %id) |
DB472414 | hippocampus | .d | 92 to 582 | 1 to 491 | exact | | | 491/491 (100 %) | 0 diff (100 %id) |
BE392153 | endometrium, adenocarcinoma cell line, uterus | .d | 92 to 584 | 1 to 493 | exact | | | 493/493 (100 %) | 0 diff (100 %id) |
BE742413 | adenocarcinoma cell line, ovary | .d | 92 to 728 | 1 to 636 | I108X | | | 636/636 (100 %) | 2 diff (99.7 %id) |
BE407596 | choriocarcinoma, placenta | .d | 96 to 853 | 1 to 754 | exact | | | 754/826 (91 %) | 18 diff (97.9 %id) |
BE901584 | choriocarcinoma, placenta | .d | 96 to 871 | 1 to 763 | exact | | | 763/921 (82 %) | 19 diff (98.0 %id) |
BY796297 | eye | .d | 97 to 673 | 1 to 577 | exact | | | 577/577 (100 %) | 1 diff (99.9 %id) |
BE910040 | epithelioid carcinoma, Pancreas | .d | 97 to 626 | 1 to 529 | exact | | | 529/529 (100 %) | 1 diff (99.9 %id) |
BM455076 | lymph, lymphoma, cell line | .d | 97 to 995 | 13 to 913 | exact | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 901/913 (98 %) | 18 diff (98.1 %id) |
CN368392 | embryonic stem cells, DMSO-treated H9 cellline | .d | 100 to 784 | 1 to 685 | exact | | | 685/685 (100 %) | 0 diff (100 %id) |
BG339944 | leiomyosarcoma cell line, uterus | .d | 100 to 869 | 1 to 759 | I93M V94S K95N H96T P97L ... | | | 759/784 (96 %) | 20 diff (97.5 %id) |
R32117 | placenta | .d | 101 to 469 | 1 to 370 | | | | 370/370 (100 %) | 5 diff (98.7 %id) |
BM477310 | lymph, lymphoma, cell line | .d | 102 to 990 | 1 to 886 | exact | | | 886/1044 (84 %) | 16 diff (98.5 %id) |
BX280448 | adenocarcinoma, ovary | .d | 103 to 580 | 1 to 478 | exact | | | 478/478 (100 %) | 0 diff (100 %id) |
CN368396 | embryonic stem cells, DMSO-treated H9 cellline | .d | 103 to 607 | 1 to 505 | exact | | | 505/505 (100 %) | 0 diff (100 %id) |
AA127733 | uterus | .d | 103 to 544 | 1 to 438 | | fully sequenced, | | 438/438 (100 %) | 3 diff (99.4 %id) |
AA133391 | uterus | .d | 103 to 495 | 1 to 394 | | fully sequenced, | | 394/394 (100 %) | 3 diff (99.3 %id) |
CR980035 | T-Lymphocytes | .d | 104 to 987 | 1 to 885 | exact | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 885/885 (100 %) | 2 diff (99.8 %id) |
TI_59381411 | | .d | 105 to 919 | 102 to 912 | I108M V109S P110Q V111S P112H ... | | | 811/890 (91 %) | 26 diff (97.1 %id) |
CF128900 | Chondrosarcoma Lung Metastasis cell lines, lung | .d | 107 to 779 | 1 to 673 | exact | | | 673/673 (100 %) | 1 diff (99.9 %id) |
TI_154189053 | | .d | 107 to 987 | 51 to 916 | exact | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 866/866 (100 %) | 25 diff (97.2 %id) |
BQ673266 | epidermoid carcinoma, cell line, salivary gland | .d | 108 to 977 | 1 to 890 | exact | | | 890/940 (94 %) | 40 diff (95.8 %id) |
DA737819 | | .d | 123 to 461 | 2 to 340 | | fully sequenced, capped | | 339/339 (100 %) | 1 diff (99.8 %id) |
CB270163 | adipose | .d | 124 to 652 | 1 to 529 | exact | | | 529/529 (100 %) | 0 diff (100 %id) |
BF034318 | adenocarcinoma, ovary | .d | 125 to 920 | 1 to 789 | exact | | | 789/829 (95 %) | 27 diff (96.8 %id) |
BE383056 | brain, neuroblastoma | .d | 143 to 852 | 1 to 709 | exact | | | 709/710 (99 %) | 8 diff (98.9 %id) |
BU502372 | mixed (pool of 40 RNAs) | .d | 160 to 920 | 1 to 766 | exact | | | 766/768 (99 %) | 15 diff (98.1 %id) |
BC051302 | Primary B-Cells from Tonsils | .d | 164 to 994 | 1 to 831 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 831/831 (100 %) | 0 diff (100 %id) |
CR597333 | Neuroblastoma Cot 10-normalized | .d | 168 to 988 | 1 to 821 | exact | | | 821/821 (100 %) | 0 diff (100 %id) |
BF827990 | head_normal | .d | 178 to 552 | 382 to 8 | | | Submitted on the opposite strand | 375/382 (98 %) | 3 diff (99.3 %id) |
TI_1948083487 | | .d | 180 to 567 | 121 to 508 | exact | | | 388/1026 (37 %) | 11 diff (99.0 %id) |
BG567405 | Liver | .d | 220 to 869 | 218 to 860 | | | | 643/867 (74 %) | 43 diff (95.1 %id) |
BI828382 | brain, medulla | .d | 221 to 944 | 9 to 732 | | | | 724/792 (91 %) | 13 diff (98.4 %id) |
TI_57175150 | | .d | 221 to 944 | 36 to 759 | | AAA | | 724/810 (89 %) | 12 diff (98.6 %id) |
BG219316 | | .d | 227 to 987 | 4 to 763 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 760/763 (99 %) | 14 diff (98.2 %id) |
AI193110 | lung | .d | 227 to 990 | 772 to 7 | | | | 766/803 (95 %) | 8 diff (99.1 %id) |
TI_149301033 | | .d | 227 to 988 | 871 to 110 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 762/950 (80 %) | 6 diff (99.4 %id) |
BG185500 | | .d | 228 to 982 | 1 to 755 | | | | 755/784 (96 %) | 8 diff (99.0 %id) |
BG203573 | | .d | 228 to 977 | 1 to 748 | | | | 748/775 (96 %) | 18 diff (97.7 %id) |
BG209867 | | .d | 228 to 971 | 1 to 741 | | | | 741/741 (100 %) | 11 diff (98.6 %id) |
BG212071 | | .d | 228 to 976 | 1 to 745 | | | | 745/767 (97 %) | 22 diff (97.2 %id) |
TI_154105493 | | .d | 228 to 994 | 849 to 84 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 766/950 (80 %) | 3 diff (99.7 %id) |
BQ069591 | brain, neuroblastoma, cell line | .d | 235 to 988 | 1 to 763 | | | | 763/1085 (70 %) | 16 diff (98.6 %id) |
CA308098 | Alveolar Macrophage, lung | .d | 250 to 994 | 763 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 745/745 (100 %) | 0 diff (100 %id) |
CD743040 | Alveolar Macrophage, lung | .d | 250 to 988 | 757 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 739/739 (100 %) | 3 diff (99.6 %id) |
AL555226 | placenta | .d | 282 to 897 | 616 to 1 | | fully sequenced, | | 616/616 (100 %) | 1 diff (99.9 %id) |
BF362271 | nervous_normal | .d | 312 to 496 | 184 to 1 | | | | 184/184 (100 %) | 3 diff (98.4 %id) |
CA446660 | Chondrosarcoma, Left Pubic Bone | .d | 314 to 994 | 698 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 680/680 (100 %) | 2 diff (99.8 %id) |
FN073759 | breast carcinoma | .d | 318 to 412 | 95 to 1 | | | Submitted on the opposite strand | 95/95 (100 %) | 0 diff (100 %id) |
BE394786 | endometrium, adenocarcinoma cell line, uterus | .d | 318 to 982 | 1 to 658 | | | | 658/746 (88 %) | 10 diff (98.7 %id) |
BG572756 | placenta | .d | 331 to 901 | 1 to 570 | | | | 570/570 (100 %) | 2 diff (99.7 %id) |
BQ771747 | Chondrosarcoma Grade II, Left Pelvis | .d | 331 to 988 | 676 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 658/661 (99 %) | 5 diff (99.3 %id) |
CA420934 | Bone, Enchondroma cell line | .d | 340 to 943 | 621 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 603/603 (100 %) | 1 diff (99.9 %id) |
BM976913 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .d | 341 to 988 | 663 to 16 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 648/648 (100 %) | 3 diff (99.6 %id) |
CA421941 | Bone, Enchondroma cell line | .d | 341 to 988 | 662 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 644/644 (100 %) | 4 diff (99.4 %id) |
BU629719 | cell lines, Chondrosarcoma | .d | 341 to 988 | 665 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 647/647 (100 %) | 3 diff (99.6 %id) |
BG217817 | | .d | 364 to 985 | 629 to 5 | | | Submitted on the opposite strand | 625/766 (81 %) | 0 diff (100 %id) |
TI_154055835 | | .d | 364 to 988 | 711 to 88 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 624/851 (73 %) | 5 diff (99.5 %id) |
CB242996 | Human Lung Epithelial cells, lung | .d | 364 to 992 | 647 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 629/636 (98 %) | 2 diff (99.7 %id) |
BG201010 | | .d | 365 to 978 | 650 to 39 | | | Submitted on the opposite strand | 612/985 (62 %) | 0 diff (100 %id) |
BG206744 | | .d | 365 to 980 | 654 to 41 | | | Submitted on the opposite strand | 614/656 (93 %) | 0 diff (100 %id) |
BG220344 | | .d | 365 to 977 | 651 to 41 | | | Submitted on the opposite strand | 611/980 (62 %) | 0 diff (100 %id) |
BG193880 | | .d | 367 to 977 | 651 to 44 | | | Submitted on the opposite strand | 608/953 (63 %) | 0 diff (100 %id) |
TI_149299398 | | .d | 367 to 988 | 701 to 83 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 619/815 (75 %) | 16 diff (98.1 %id) |
BE858118 | brain, glioblastoma (pooled) | .d | 368 to 943 | 577 to 1 | | | | 577/577 (100 %) | 1 diff (99.9 %id) |
BG207800 | | .d | 370 to 977 | 650 to 44 | | | Submitted on the opposite strand | 607/651 (93 %) | 0 diff (100 %id) |
BF916053 | uterus_tumor | .d | 374 to 665 | 293 to 2 | | | Submitted on the opposite strand | 292/293 (99 %) | 0 diff (100 %id) |
BG198940 | | .d | 375 to 977 | 633 to 45 | | | Submitted on the opposite strand | 589/917 (64 %) | 0 diff (100 %id) |
AA748042 | germinal center B cell | .d | 378 to 943 | 581 to 16 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 566/566 (100 %) | 1 diff (99.9 %id) |
BM041489 | Kidney, Wilms' tumor, cell line | .d | 392 to 868 | 481 to 1 | | fully sequenced, | | 481/481 (100 %) | 5 diff (99.0 %id) |
FN130871 | breast carcinoma | .d | 399 to 471 | 1 to 73 | | | | 73/73 (100 %) | 5 diff (93.2 %id) |
AI300529 | 2 pooled tumors (clear cell type), Kidney | .d | 411 to 990 | 582 to 3 | | | | 580/582 (99 %) | 0 diff (100 %id) |
AA099271 | uterus | .d | 422 to 992 | 1 to 570 | | fully sequenced, | | 570/570 (100 %) | 3 diff (99.5 %id) |
FN142655 | breast carcinoma | .d | 425 to 530 | 1 to 109 | | | | 109/109 (100 %) | 3 diff (97.3 %id) |
CA418734 | Chondrosarcoma Grade II, Left Pelvis | .d | 430 to 988 | 577 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 559/559 (100 %) | 1 diff (99.9 %id) |
DB370439 | | .d | 434 to 994 | 558 to 1 | | fully sequenced, | | 558/558 (100 %) | 15 diff (97.4 %id) |
CB108844 | Liver | .d | 439 to 988 | 1 to 550 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 550/550 (100 %) | 1 diff (99.9 %id) |
BE092679 | breast | .d | 455 to 652 | 204 to 10 | | | Submitted on the opposite strand | 195/205 (95 %) | 0 diff (100 %id) |
BE092692 | breast | .d | 461 to 657 | 202 to 6 | | | Submitted on the opposite strand | 197/202 (97 %) | 0 diff (100 %id) |
BE395461 | endometrium, adenocarcinoma cell line, uterus | .d | 463 to 978 | 1 to 515 | | | | 515/516 (99 %) | 3 diff (99.5 %id) |
AA115634 | uterus | .d | 465 to 992 | 545 to 1 | | fully sequenced, | | 545/545 (100 %) | 19 diff (96.6 %id) |
BF197135 | pooled | .d | 467 to 990 | 527 to 4 | | | | 524/527 (99 %) | 0 diff (100 %id) |
AW975854 | | .d | 470 to 987 | 518 to 1 | | | Submitted on the opposite strand | 518/519 (99 %) | 44 diff (91.6 %id) |
AW380356 | head_neck | .d | 478 to 894 | 422 to 6 | | | | 417/435 (95 %) | 0 diff (100 %id) |
AW380375 | head_neck | .d | 478 to 883 | 408 to 1 | | | | 408/421 (96 %) | 7 diff (98.4 %id) |
AW380377 | head_neck | .d | 478 to 830 | 352 to 1 | | | | 352/365 (96 %) | 7 diff (98.1 %id) |
AW380384 | head_neck | .d | 478 to 884 | 410 to 4 | | | | 407/423 (96 %) | 0 diff (100 %id) |
BG210924 | | .d | 480 to 992 | 517 to 5 | | | Submitted on the opposite strand | 513/726 (70 %) | 0 diff (100 %id) |
BE350408 | leukoplakia of the buccal mucosa, mouth | .d | 480 to 911 | 452 to 22 | | | Submitted on the opposite strand | 431/452 (95 %) | 0 diff (100 %id) |
AI808491 | pooled | .d | 481 to 988 | 524 to 17 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 508/508 (100 %) | 2 diff (99.7 %id) |
R32118 | placenta | .d | 482 to 974 | 504 to 12 | | | | 493/507 (97 %) | 0 diff (100 %id) |
AI336265 | lung | .d | 482 to 990 | 509 to 1 | | | | 509/509 (100 %) | 1 diff (99.9 %id) |
AI832813 | colon | .d | 482 to 990 | 510 to 2 | | | | 509/510 (99 %) | 0 diff (100 %id) |
AI160012 | uterus | .d | 485 to 990 | 506 to 1 | | | | 506/506 (100 %) | 1 diff (99.9 %id) |
AW380370 | head_neck | .d | 487 to 810 | 351 to 21 | | | | 331/376 (88 %) | 0 diff (100 %id) |
AI359397 | brain, glioblastoma (pooled) | .d | 487 to 943 | 457 to 1 | | | | 457/457 (100 %) | 1 diff (99.8 %id) |
AW294804 | | .d | 487 to 988 | 519 to 18 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 502/502 (100 %) | 4 diff (99.3 %id) |
DB541171 | hippocampus | .d | 488 to 949 | 1 to 462 | | | Submitted on the opposite strand | 462/464 (99 %) | 1 diff (99.8 %id) |
AA029612 | heart | .d | 492 to 994 | 1 to 504 | | fully sequenced, | | 504/504 (100 %) | 3 diff (99.5 %id) |
BE745425 | adenocarcinoma cell line, ovary | .d | 492 to 992 | 1 to 499 | | | | 499/499 (100 %) | 4 diff (99.2 %id) |
AI336001 | lung | .d | 501 to 944 | 448 to 5 | | | | 444/448 (99 %) | 0 diff (100 %id) |
AA722195 | pineal gland | .d | 507 to 990 | 485 to 2 | | | | 484/485 (99 %) | 0 diff (100 %id) |
BU553076 | ovary, teratocarcinoma, cell line | .d | 508 to 988 | 1 to 481 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 481/481 (100 %) | 1 diff (99.8 %id) |
AI570532 | anaplastic oligodendroglioma, brain | .d | 513 to 988 | 476 to 1 | | | | 476/476 (100 %) | 4 diff (99.2 %id) |
AA121508 | uterus | .d | 514 to 992 | 472 to 1 | | fully sequenced, | | 472/472 (100 %) | 3 diff (99.4 %id) |
AA865682 | 2 pooled tumors (clear cell type), Kidney | .d | 514 to 953 | 442 to 3 | | | | 440/442 (99 %) | 0 diff (100 %id) |
DB566332 | hypothalamus | .d | 519 to 988 | 1 to 470 | | | Submitted on the opposite strand | 470/470 (100 %) | 0 diff (100 %id) |
DB571303 | hypothalamus | .d | 519 to 994 | 1 to 476 | | | Submitted on the opposite strand | 476/476 (100 %) | 0 diff (100 %id) |
DB576401 | hypothalamus | .d | 520 to 987 | 1 to 468 | | | Submitted on the opposite strand | 468/468 (100 %) | 3 diff (99.4 %id) |
DB571304 | hypothalamus | .d | 521 to 994 | 1 to 474 | | | Submitted on the opposite strand | 474/474 (100 %) | 2 diff (99.6 %id) |
AI911906 | colon | .d | 522 to 947 | 426 to 1 | | | | 426/426 (100 %) | 1 diff (99.8 %id) |
DB576402 | hypothalamus | .d | 523 to 987 | 1 to 465 | | | Submitted on the opposite strand | 465/465 (100 %) | 3 diff (99.4 %id) |
AI141465 | heart | .d | 523 to 990 | 470 to 3 | | | | 468/470 (99 %) | 0 diff (100 %id) |
AI680468 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .d | 523 to 944 | 427 to 6 | | | | 422/427 (98 %) | 0 diff (100 %id) |
DB574012 | hypothalamus | .d | 524 to 989 | 1 to 466 | | | Submitted on the opposite strand | 466/468 (99 %) | 3 diff (99.4 %id) |
AI190286 | heart | .d | 524 to 944 | 422 to 2 | | | | 421/422 (99 %) | 0 diff (100 %id) |
AI857944 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .d | 524 to 990 | 467 to 1 | | | | 467/467 (100 %) | 1 diff (99.8 %id) |
DB527542 | testis | .d | 525 to 988 | 1 to 464 | | | Submitted on the opposite strand | 464/464 (100 %) | 0 diff (100 %id) |
AI342221 | uterus | .d | 525 to 988 | 464 to 1 | | | | 464/464 (100 %) | 2 diff (99.6 %id) |
DB563822 | hypothalamus | .d | 528 to 988 | 1 to 460 | | | Submitted on the opposite strand | 460/460 (100 %) | 4 diff (99.2 %id) |
DB566326 | hypothalamus | .d | 528 to 994 | 1 to 467 | | | Submitted on the opposite strand | 467/467 (100 %) | 0 diff (100 %id) |
BE350073 | 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney | .d | 528 to 987 | 477 to 18 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 460/460 (100 %) | 2 diff (99.6 %id) |
DB566478 | hypothalamus | .d | 529 to 988 | 1 to 459 | | | Submitted on the opposite strand | 459/459 (100 %) | 2 diff (99.6 %id) |
AI862033 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .d | 529 to 988 | 460 to 1 | | | | 460/460 (100 %) | 1 diff (99.8 %id) |
DB542652 | hippocampus | .d | 530 to 987 | 1 to 458 | | | Submitted on the opposite strand | 458/458 (100 %) | 0 diff (100 %id) |
AI096365 | uterus | .d | 531 to 990 | 463 to 4 | | | | 460/463 (99 %) | 0 diff (100 %id) |
BG656477 | Pancreas, Purified pancreatic islet | .d | 542 to 989 | 448 to 1 | | | Submitted on the opposite strand | 448/448 (100 %) | 2 diff (99.6 %id) |
BM975659 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .d | 542 to 988 | 465 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 447/447 (100 %) | 1 diff (99.8 %id) |
AI361255 | brain, glioblastoma (pooled) | .d | 543 to 989 | 447 to 1 | | | | 447/447 (100 %) | 1 diff (99.8 %id) |
AI954960 | four pooled poorly-differentiatedadenocarcinomas, lung | .d | 543 to 988 | 460 to 15 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 446/446 (100 %) | 2 diff (99.6 %id) |
AI371048 | lung | .d | 544 to 988 | 445 to 1 | | | | 445/445 (100 %) | 0 diff (100 %id) |
DB525374 | testis | .d | 545 to 988 | 1 to 444 | | | Submitted on the opposite strand | 444/444 (100 %) | 1 diff (99.8 %id) |
DB556974 | hypothalamus | .d | 546 to 988 | 1 to 444 | | | Submitted on the opposite strand | 444/444 (100 %) | 9 diff (98.0 %id) |
DB553627 | hypothalamus | .d | 549 to 987 | 1 to 439 | | | Submitted on the opposite strand | 439/439 (100 %) | 3 diff (99.4 %id) |
AI091483 | pooled | .d | 551 to 988 | 450 to 13 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 438/438 (100 %) | 2 diff (99.6 %id) |
AI559677 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .d | 551 to 988 | 459 to 22 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 438/438 (100 %) | 1 diff (99.8 %id) |
BU191142 | melanotic melanoma, cell line, skin | .d | 561 to 994 | 1 to 434 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 434/434 (100 %) | 1 diff (99.8 %id) |
AI346804 | adenocarcinoma, colon | .d | 570 to 988 | 419 to 1 | | | | 419/419 (100 %) | 1 diff (99.8 %id) |
AI130942 | heart | .d | 571 to 994 | 426 to 3 | | | | 424/426 (99 %) | 0 diff (100 %id) |
DB562981 | hypothalamus | .d | 574 to 988 | 1 to 415 | | | Submitted on the opposite strand | 415/416 (99 %) | 2 diff (99.6 %id) |
DB559222 | hypothalamus | .d | 580 to 989 | 1 to 410 | | | Submitted on the opposite strand | 410/412 (99 %) | 3 diff (99.3 %id) |
AA688307 | normal prostate, Prostate | .d | 580 to 988 | 409 to 1 | | | | 409/409 (100 %) | 0 diff (100 %id) |
AW189276 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .d | 581 to 990 | 412 to 4 | | | | 409/412 (99 %) | 0 diff (100 %id) |
AI189025 | placenta | .d | 582 to 987 | 407 to 1 | | | | 407/407 (100 %) | 2 diff (99.6 %id) |
AI767694 | Kidney | .d | 584 to 988 | 405 to 1 | | | | 405/405 (100 %) | 2 diff (99.6 %id) |
AW614333 | Kidney | .d | 604 to 990 | 388 to 2 | | | | 387/388 (99 %) | 0 diff (100 %id) |
AI354954 | lung | .d | 609 to 987 | 379 to 1 | | | | 379/379 (100 %) | 1 diff (99.8 %id) |
H99705 | melanocyte | .d | 623 to 988 | 378 to 11 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 368/368 (100 %) | 3 diff (99.2 %id) |
EC492758 | Prostate | .d | 635 to 740 | 1 to 106 | | | | 106/106 (100 %) | 0 diff (100 %id) |
AA470877 | colon | .d | 635 to 946 | 312 to 1 | | | | 312/312 (100 %) | 1 diff (99.7 %id) |
AA564293 | normal prostate, Prostate | .d | 648 to 954 | 308 to 1 | | | | 308/308 (100 %) | 2 diff (99.4 %id) |
AI301595 | carcinoid, lung | .d | 649 to 989 | 341 to 1 | | | | 341/341 (100 %) | 3 diff (99.2 %id) |
AI982790 | pooled germ cell tumors | .d | 660 to 988 | 329 to 1 | | | | 329/329 (100 %) | 1 diff (99.7 %id) |
AW237470 | Kidney | .d | 660 to 987 | 328 to 1 | | | | 328/328 (100 %) | 0 diff (100 %id) |
BE671766 | pooled germ cell tumors | .d | 660 to 988 | 329 to 1 | | | | 329/329 (100 %) | 1 diff (99.7 %id) |
BE671907 | pooled germ cell tumors | .d | 660 to 988 | 329 to 1 | | | | 329/329 (100 %) | 3 diff (99.1 %id) |
BF059385 | pooled germ cell tumors | .d | 660 to 988 | 329 to 1 | | | | 329/329 (100 %) | 1 diff (99.7 %id) |
AW271629 | Kidney | .d | 665 to 988 | 340 to 17 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 324/324 (100 %) | 1 diff (99.7 %id) |
AA026111 | heart | .d | 666 to 993 | 328 to 1 | | fully sequenced, | | 328/328 (100 %) | 1 diff (99.7 %id) |
FN096737 | breast carcinoma | .d | 671 to 730 | 9 to 68 | | | | 60/69 (86 %) | 1 diff (98.6 %id) |
AA853830 | Bone, Hip | .d | 671 to 964 | 299 to 6 | | | | 294/299 (98 %) | 0 diff (100 %id) |
BU734441 | eye, RPE and Choroid | .d | 686 to 988 | 321 to 19 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 303/303 (100 %) | 2 diff (99.4 %id) |
CN368395 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .d | 688 to 899 | 1 to 212 | | | | 212/212 (100 %) | 2 diff (99.1 %id) |
AA098892 | uterus | .d | 692 to 994 | 311 to 1 | | fully sequenced, | | 311/311 (100 %) | 5 diff (98.4 %id) |
AA468597 | colon | .d | 703 to 990 | 288 to 1 | | | | 288/288 (100 %) | 0 diff (100 %id) |
BF348966 | denis_drash | .d | 709 to 912 | 204 to 1 | | | | 204/204 (100 %) | 9 diff (95.6 %id) |
BE175251 | head_neck | .d | 736 to 951 | 246 to 30 | | | Submitted on the opposite strand | 217/260 (83 %) | 0 diff (100 %id) |
FN109062 | breast carcinoma | .d | 741 to 843 | 102 to 1 | | | Submitted on the opposite strand | 102/102 (100 %) | 2 diff (98.1 %id) |
AI758913 | Kidney | .d | 762 to 988 | 227 to 1 | | | | 227/227 (100 %) | 0 diff (100 %id) |
DV462638 | cochlea, ear | .d | 766 to 987 | 254 to 33 | | AAA | Submitted on the opposite strand | 222/223 (99 %) | 0 diff (100 %id) |
C00620 | | .d | 773 to 988 | 1 to 216 | | | | 216/216 (100 %) | 0 diff (100 %id) |
BM768223 | stomach | .d | 790 to 988 | 1 to 199 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 199/199 (100 %) | 0 diff (100 %id) |
EB362761 | eye, lens | .d | 821 to 994 | 208 to 35 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 174/174 (100 %) | 0 diff (100 %id) |
BE708601 | head_neck | .d | 841 to 981 | 141 to 1 | | | | 141/163 (86 %) | 4 diff (97.6 %id) |
EH355778 | | .d | 914 to 990 | 1 to 76 | | | | 76/76 (100 %) | 4 diff (94.8 %id) |
CN368394 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .e | 1 to 649 | 1 to 650 | exact | tiling clone, | | 650/650 (100 %) | 6 diff (99.1 %id) |
BF726865 | eye, lens | .f | 1 to 534 | 1 to 534 | exact | tiling clone, | | 534/534 (100 %) | 0 diff (100 %id) |
DA854348 | placenta | .g | 1 to 594 | 2 to 595 | | tiling clone, capped | | 594/594 (100 %) | 0 diff (100 %id) |
BG718840 | testis | .g | 69 to 813 | 1 to 740 | | available from MGC, | | 740/747 (99 %) | 27 diff (96.4 %id) |
BC042752 | testis | .g | 74 to 4001 | 1 to 3926 | exact | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 3926/3926 (100 %) | 3 diff (100.0 %id) |
DB136330 | thymus | .g | 272 to 663 | 2 to 392 | | capped | | 391/391 (100 %) | 1 diff (99.8 %id) |
DB157912 | thymus | .g | 315 to 894 | 2 to 581 | | tiling clone, capped | | 580/580 (100 %) | 2 diff (99.7 %id) |
DB229690 | trachea | .g | 570 to 1143 | 2 to 576 | | capped | | 575/575 (100 %) | 2 diff (99.7 %id) |
AA834090 | Kidney, kidney tumor | .g | 628 to 743 | 1 to 116 | | | | 116/116 (100 %) | 1 diff (99.2 %id) |
DA549345 | | .g | 1368 to 1939 | 2 to 573 | | capped | | 572/572 (100 %) | 0 diff (100 %id) |
DA960439 | Spleen | .g | 1496 to 2039 | 2 to 546 | | tiling clone, capped | | 545/545 (100 %) | 1 diff (99.9 %id) |
DA374220 | thalamus | .g | 1501 to 2052 | 2 to 554 | | capped | | 553/553 (100 %) | 2 diff (99.7 %id) |
CV370749 | testis_normal | .g | 1753 to 1895 | 148 to 2 | | | Submitted on the opposite strand | 147/154 (95 %) | 0 diff (100 %id) |
DA747572 | | .g | 1854 to 2415 | 2 to 563 | | tiling clone, capped | | 562/562 (100 %) | 0 diff (100 %id) |
BG961522 | colon | .g | 2462 to 2604 | 156 to 13 | | | | 144/156 (92 %) | 0 diff (100 %id) |
AA827788 | germinal center B cell | .g | 2496 to 2790 | 294 to 1 | | | | 294/294 (100 %) | 3 diff (99.0 %id) |
CD101808 | Blood vessels - aorta, basilar and artery | .g | 2627 to 3317 | 1 to 694 | | | | 694/743 (93 %) | 4 diff (99.5 %id) |
BI042406 | nervous_tumor | .g | 2802 to 2971 | 6 to 179 | | | | 174/183 (95 %) | 11 diff (94.0 %id) |
CV423249 | nervous_tumor | .g | 2802 to 2971 | 6 to 179 | | | | 174/183 (95 %) | 11 diff (94.0 %id) |
BM713560 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .g | 2908 to 3411 | 1 to 504 | | fully sequenced, | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 504/504 (100 %) | 0 diff (100 %id) |
BM798363 | Ascites, stomach | .g | 3106 to 3559 | 1 to 454 | | | | 454/454 (100 %) | 3 diff (99.4 %id) |
CB128704 | Liver | .g | 3196 to 3797 | 1 to 602 | exact | | | 602/602 (100 %) | 1 diff (99.9 %id) |
BU739587 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .g | 3353 to 4001 | 667 to 19 | | fully sequenced, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 649/649 (100 %) | 0 diff (100 %id) |
DB325013 | | .g | 3462 to 4001 | 541 to 1 | | | | 541/541 (100 %) | 2 diff (99.7 %id) |
DB345026 | thymus | .g | 3465 to 4007 | 543 to 1 | | | | 543/543 (100 %) | 3 diff (99.5 %id) |
CB106520 | Liver | .h | 1 to 422 | 2 to 424 | exact | tiling clone, | | 424/424 (100 %) | 1 diff (99.8 %id) |
BP198334 | adrenal gland | .h | 2 to 583 | 1 to 582 | exact | | | 582/582 (100 %) | 1 diff (99.9 %id) |
BU622555 | cell lines, Chondrosarcoma | .h | 92 to 790 | 717 to 19 | | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 699/699 (100 %) | 0 diff (100 %id) |
AF426258 | | .i | 1 to 654 | 1 to 654 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 654/654 (100 %) | 0 diff (100 %id) |
NR_027267.1 | | .i | 1 to 654 | 1 to 654 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 654/654 (100 %) | 0 diff (100 %id) |
AA007432 | liver and spleen | .i | 42 to 314 | 1 to 275 | K61R L63T | | | 275/283 (97 %) | 6 diff (97.9 %id) |
BX098800 | lung | .i | 46 to 645 | 1 to 600 | exact | | | 600/600 (100 %) | 0 diff (100 %id) |
BC093749 | Brain, cerebellum, PCR rescued clones | .i | 71 to 346 | 1 to 276 | exact | | | 276/276 (100 %) | 0 diff (100 %id) |
BC111996 | Brain, cerebellum, PCR rescued clones | .i | 71 to 353 | 1 to 283 | exact | | | 283/283 (100 %) | 0 diff (100 %id) |
AI423249 | brain, glioblastoma (pooled) | .i | 207 to 654 | 448 to 1 | | | | 448/448 (100 %) | 2 diff (99.6 %id) |
BF477347 | brain, glioblastoma (pooled) | .i | 225 to 654 | 430 to 1 | | | | 430/430 (100 %) | 0 diff (100 %id) |
AI919214 | brain, glioblastoma (pooled) | .i | 230 to 654 | 425 to 1 | | | | 425/425 (100 %) | 0 diff (100 %id) |
AI027483 | brain, glioblastoma (pooled) | .i | 288 to 655 | 370 to 3 | | | | 368/370 (99 %) | 0 diff (100 %id) |
AW139993 | | .i | 288 to 654 | 384 to 18 | | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 367/367 (100 %) | 0 diff (100 %id) |
N79996 | lung | .i | 353 to 654 | 306 to 1 | | | | 306/306 (100 %) | 5 diff (98.4 %id) |
AI471119 | brain, glioblastoma (pooled) | .i | 522 to 654 | 133 to 1 | | | | 133/133 (100 %) | 0 diff (100 %id) |
AK055913 | | .j-u | 1 to 2882 | 2 to 2885 | exact | tiling clone, available from FLJ, | | 2885/2885 (100 %) | 27 diff (99.1 %id) |
DA647710 | | .j-u | 1 to 563 | 2 to 566 | | capped | | 565/565 (100 %) | 10 diff (98.3 %id) |
BF753979 | colon | .j-u | 519 to 921 | 1 to 403 | | | | 403/403 (100 %) | 12 diff (97.1 %id) |
DB321595 | | .j-u | 2337 to 2882 | 549 to 1 | | tiling clone, | | 549/549 (100 %) | 17 diff (97.0 %id) |
AK096374 | | .k | 1 to 1949 | 2 to 1951 | exact | tiling clone, available from FLJ, | | 1951/1951 (100 %) | 2 diff (99.9 %id) |
DA666669 | | .l | 1 to 550 | 2 to 551 | exact | tiling clone, capped | | 550/550 (100 %) | 0 diff (100 %id) |
CD512568 | Pooled-Skin | .l | 299 to 1026 | 1 to 735 | | tiling clone, | | 735/758 (96 %) | 12 diff (98.5 %id) |
W65378 | heart | .l | 971 to 1428 | 1 to 459 | | tiling clone, fully sequenced, | | 459/459 (100 %) | 1 diff (99.8 %id) |
W61117 | heart | .l | 1398 to 1773 | 375 to 1 | | tiling clone, fully sequenced, | | 375/375 (100 %) | 1 diff (99.8 %id) |
NR_027266.1 | | .m | 1 to 1269 | 1 to 1269 | exact | RefSeq, tiling clone, | | 1269/1269 (100 %) | 0 diff (100 %id) |
AK092704 | skeletal muscle | .m | 72 to 1269 | 1 to 1198 | exact | available from FLJ, | | 1198/1198 (100 %) | 0 diff (100 %id) |
DA900437 | skeletal muscle | .m | 73 to 641 | 2 to 571 | D33* | capped | | 570/570 (100 %) | 1 diff (99.9 %id) |
BM695339 | eye, optic nerve | .m | 104 to 737 | 1 to 634 | exact | fully sequenced, | | 634/634 (100 %) | 0 diff (100 %id) |
DA727829 | | .m | 178 to 512 | 2 to 336 | | capped | | 335/338 (99 %) | 2 diff (99.5 %id) |
BI002334 | head_normal | .m | 259 to 699 | 1 to 438 | | | | 438/438 (100 %) | 8 diff (98.2 %id) |
BM664988 | eye, optic nerve | .m | 707 to 1264 | 587 to 29 | | fully sequenced, | | 559/587 (95 %) | 1 diff (99.9 %id) |
DB331117 | skeletal muscle | .m | 731 to 1269 | 539 to 1 | | | | 539/539 (100 %) | 0 diff (100 %id) |
DB450512 | testis | .n | 1 to 434 | 1 to 434 | Q45K | tiling clone, | | 434/434 (100 %) | 7 diff (98.4 %id) |
BX282240 | brain, medulla | .n | 26 to 570 | 1 to 545 | | | | 545/545 (100 %) | 0 diff (100 %id) |
BI829895 | brain, medulla | .n | 26 to 856 | 1 to 830 | | tiling clone, | | 830/830 (100 %) | 7 diff (99.2 %id) |
TI_57176479 | | .n | 26 to 856 | 40 to 869 | | | | 830/869 (95 %) | 13 diff (98.6 %id) |
BU508954 | leiomyosarcoma, uterus | .o | 1 to 797 | 1 to 807 | exact | tiling clone, | | 807/926 (87 %) | 22 diff (97.7 %id) |
BE384195 | melanotic melanoma, skin | .o | 21 to 748 | 1 to 721 | exact | tiling clone, | | 721/723 (99 %) | 14 diff (98.1 %id) |
BE384048 | melanotic melanoma, skin | .o | 21 to 540 | 1 to 520 | exact | | | 520/520 (100 %) | 0 diff (100 %id) |
BG199472 | | .p | 1 to 784 | 5 to 788 | H25L | tiling clone, | | 788/789 (99 %) | 23 diff (97.1 %id) |
BI087343 | cervix | .q | 1 to 766 | 1 to 779 | exact | tiling clone, | | 777/779 (99 %) | 18 diff (97.7 %id) |
BG462147 | | .q | 420 to 668 | 50 to 297 | | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 248/297 (83 %) | 6 diff (98.0 %id) |
DA406094 | thalamus | .r | 1 to 603 | 2 to 604 | exact | tiling clone, capped | | 603/603 (100 %) | 1 diff (99.9 %id) |
ES308294 | beard hair, skin | .r | 69 to 202 | 1 to 131 | | | | 131/133 (98 %) | 4 diff (97.0 %id) |
DB080492 | testis | .s | 1 to 574 | 2 to 573 | T50A | tiling clone, capped | | 572/572 (100 %) | 3 diff (99.5 %id) |
Z36963 | | .t | 1 to 391 | 6 to 396 | exact | tiling clone, | | 396/396 (100 %) | 0 diff (100 %id) |
BF826686 | head_normal | Gene MRPS6andSLC5A3andC21orf82, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
DB484631 | hypothalamus | Gene MRPS6andSLC5A3andC21orf82, variant not shown | | | | | This clone was ignored | | |
AV727688 | hypothalamus | Gene MRPS6andSLC5A3andC21orf82, variant not shown | | | | | Submitted on the opposite strand, submitted on the opposite strand | | |
CA337294 | posterior rhombomeres 5-8 (4 pooled) | Gene MRPS6andSLC5A3andC21orf82, variant not shown | | | | | Submitted on the opposite strand | | |
TI_57166317 | | Gene MRPS6andSLC5A3andC21orf82, variant not shown | | | | | Suspected internal deletion, this clone was ignored | | |
DA706316 | | Gene MRPS6andSLC5A3andC21orf82, variant not shown | | | | capped | | | |
DB323996 | | Gene MRPS6andSLC5A3andC21orf82, variant not shown | | | | | | | |
DA706330 | | Gene MRPS6andSLC5A3andC21orf82, variant not shown | | | | capped | | | |
? | Gene Summary |
Gene on genome |
mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t |
Alternative mRNAs features, proteins, introns, exons, sequences |
Expression Tissue |
Function, regulation, related genes DCI |
To mine knowledge about the gene, please click the 'Gene Summary' or the 'Function, regulation, related genes ' tab at the top of the page. The 'Gene Summary' page includes all we learnt about the gene, functional annotations of neighboring genes, maps, links to other sites and the bibliography. The 'Function, regulation, related genes ' page includes Diseases (D), Pathways, GO annotations, conserved domains (C), interactions (I) reference into function, and pointers to all genes with the same functional annotation.
To compare alternative variants, their summarized annotations, predicted proteins, introns and exons, or to access any sequence, click the 'Alternative mRNAs features' tab. To see a specific mRNA variant diagram, sequence and annotation, click the variant name in the 'mRNA' tab. To examine expression data from all cDNAs clustered in this gene by AceView, click the 'Expression tissue'.
If you know more about this gene, or found errors, please share your knowledge. Thank you !